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The randomized controlled trial has emerged as the gold
standard for all clinical research. The combination of ran-
domized assignment to groups, use of strict inclusion and
exclusion criteria, standardized protocols and ad hoc
power analysis serve to rule out many threats to the inter-
nal validity of research results. Thus, it is the most power-
ful methodology available to researchers investigating the
relative effectiveness of treatments.
To date, there have been only 2 randomized studies exam-
ining the effectiveness of bracing for adolescent idiopathic
scoliosis. The purpose of this presentation is to discuss the
planning and the current status of the Bracing in Adoles-
cent Scoliosis Trial (BrAIST). This five-year, > $5 million
project includes 27 healthcare centers, and is funded by
the United States National Institutes of Health, the Cana-
dian Institute of Health Research, and the Shriners Hospi-
tals. Additionally, 3 institutions, including the Chinese
University of Hong Kong, are participating using internal
funding.
The protocol randomizes children with AIS who are at
high risk for curve progression to treatment with a thora-
columbosacral orthosis or to clinical monitoring. The
study is currently in its second year of recruitment.
BrAIST incorporates several innovations never used in a
single study to date:
1) randomization,
2) objective brace dose monitoring,
3) standardized, objective radiographic measurement,
4) comprehensive radiographic, clinical, and psychosocial
testing,
5) diversity of participating sites and
6) ad hoc determination of effect size, based on the risk/
benefit considerations of potential patients.
Issues to be discussed include
• Ethics - rationale for the ethics of an observation arm
￿ Protocol development and implementation - endpoints,
measures, quality assurance
￿ Recruitment and randomization - expectations and actu-
ality
￿ Bracing quality control - independent review of in-brace
films
￿ Patient/family decision-making - impact of information
and being offered a choice
￿ Brace compliance monitoring - reliability/validity of
temperature as proxy for dose
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